glucagon-like peptide-2

Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study

18. April 2023

Nutrients.2023 Apr 18;15(8):1949. doi: 10.3390/nu15081949. Elisabeth Blüthner, Ulrich-Frank Pape, Frank Tacke, Sophie Greif PMID: 37111167 DOI: 10.3390/nu15081949 Abstract Background: Quality of life (QoL) data of chronic intestinal failure (cIF) patients treated with the GLP-2 analogue teduglutide are scarce. This study aims to analyze QoL changes over time in teduglutide-treated patients and compare the results to a matched non-treated cIF control […]

Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study Weiterlesen »

Intestinale Rehabilitation bei Kurzdarmsyndrom und chronischem Darmversagen

Dtsch Med Wochenschr 2019; 144(15): 1061-1066 Ulrich-Frank Pape, Sebastian MaasbergDOI: 10.1055/a-0651-4481 Abstract Patients with severely orally decompensated malsaborption due to surgical rescetion suffer from short bowel syndrome (SBS). The resultant decrease in intestinal surface area after rescetion of parts of the intestines leads to chronic functional intestinal insufficiency or even complete failure (cIF) which requires parenteral